Global effort to unlock secrets of rare lung disease
NCT ID NCT03517865
First seen Jan 04, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study gathers medical information from 3400 people with primary ciliary dyskinesia (PCD), a rare disease that affects the lungs and other organs. Researchers will analyze past and new data on symptoms, lung function, and test results to better understand the disease and how it progresses. The goal is to improve diagnosis and treatment for people with PCD worldwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CILIARY DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Bern
Bern, 3012, Switzerland
Conditions
Explore the condition pages connected to this study.